Evidence map›Paper›PMID 30046643›Full record

ArticleOpen forum infectious diseases2018

Increasing Age Has Limited Impact on Risk of

Margaret A Olsen, Dustin Stwalley, Clarisse Demont, Erik R Dubberke

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Microbial genomics · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Incidence, healthcare and out-of-pocket costs, and mortality ofAntimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Article
  10. Informing estimates of probability ofAntimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Article
  11. Review
  12. Article
  13. Healthcare Costs ofOpen forum infectious diseases · 2023
    Article
  14. Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  15. Article
  16. Treatment and outcomes among patients ≥85 years hospitalized with community-acquired pneumonia.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2022
    Article
  17. Epidemiology and Prevention of Healthcare-Associated Infections in Geriatric Patients: A Narrative Review.International journal of environmental research and public health · 2021
    Review
  18. Gastroenterology research · 2021
    Article
  19. Infections in the older population: what do we know?Aging clinical and experimental research · 2021
    Article
  20. Characteristics, Risk Factors, and Prevalence ofInfection and drug resistance · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Margaret A OlsenDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri.
Dustin StwalleyDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri.
Clarisse DemontSanofi-Pasteur, Lyon, France.
Erik R DubberkeDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri.
Washington University in St. Louis · USSanofi (France) · FR

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
WASHINGTON UNIVERSITY COMPARATIVE EFFECTIVENESS ADMINISTRATIVE DATA REPOSITORYR24HS019455 · AHRQ · WASHINGTON UNIVERSITY · PI FRASER, VICTORIA J. · 2010 to 2010
$969k
AHRQ HHS R24 HS019455NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345
6 · The paper itself

Abstract

backgroundNumerous studies have found increased risk of

methodsA total of 174 903 persons aged 66 years and older coded for CDI in 2011 were identified using Medicare claims data. The comparison population consisted of 1 453 867 uninfected persons. Potential risk factors for CDI were identified in the prior 12 months and organized into categories, including infections, acute noninfectious conditions, chronic comorbidities, frailty indicators, and health care utilization. Multivariable logistic regression models with CDI as the dependent variable were used to determine the categories with the biggest impact on model performance.

resultsIncreasing age was associated with progressively increasing risk of CDI in univariate analysis, with 5-fold increased risk of CDI in 94-95-year-old persons compared with those aged 66-67 years. Independent risk factors for CDI with the highest effect sizes included septicemia (odds ratio [OR], 4.1), emergency hospitalization(s) (OR, 3.9), short-term skilled nursing facility stay(s) (OR, 2.7), diverticulitis (OR, 2.2), and pneumonia (OR, 2.1). Exclusion of age from the full model had no impact on model performance. Exclusion of acute noninfectious conditions followed by frailty indicators resulted in lower c-statistics and poor model fit. Further exclusion of health care utilization variables resulted in a large drop in the c-statistic.

conclusionsAge did not improve CDI risk prediction after controlling for a wide variety of infections, other acute conditions, frailty indicators, and prior health care utilization.

Indexed as

ageClostridium difficileepidemiologyMedicarerisk factor

Identifiers

PMID30046643
PMCPMC6054265
OpenAlexW2884874093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.